Marianne E. Buck

1.6k total citations · 1 hit paper
5 papers, 1.2k citations indexed

About

Marianne E. Buck is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Marianne E. Buck has authored 5 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Cardiology and Cardiovascular Medicine and 2 papers in Physiology. Recurrent topics in Marianne E. Buck's work include Adenosine and Purinergic Signaling (2 papers), Cardiac electrophysiology and arrhythmias (2 papers) and Ion channel regulation and function (2 papers). Marianne E. Buck is often cited by papers focused on Adenosine and Purinergic Signaling (2 papers), Cardiac electrophysiology and arrhythmias (2 papers) and Ion channel regulation and function (2 papers). Marianne E. Buck collaborates with scholars based in United States. Marianne E. Buck's co-authors include Steven A. Goldstein, Mark T. Keating, Federico Sesti, Katherine W. Timothy, Michael H. Lehmann, Igor Splawski, Geoffrey W. Abbott, Margaret H. Butler, Patrick G. Gallagher and Coeli M. Lopes and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Marianne E. Buck

5 papers receiving 1.2k citations

Hit Papers

MiRP1 Forms IKr Potassium Channels with HERG and Is Assoc... 1999 2026 2008 2017 1999 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marianne E. Buck United States 5 1.1k 972 324 58 44 5 1.2k
Aldo A. Rodríguez‐Menchaca Mexico 17 619 0.6× 354 0.4× 328 1.0× 14 0.2× 52 1.2× 46 771
R P Xiao United States 5 630 0.6× 553 0.6× 219 0.7× 25 0.4× 24 0.5× 7 805
Fabiana S. Scornik Spain 20 875 0.8× 792 0.8× 267 0.8× 13 0.2× 18 0.4× 39 1.2k
Csaba Szegedi Hungary 14 472 0.4× 266 0.3× 156 0.5× 44 0.8× 56 1.3× 18 598
Elisa Bovo United States 17 727 0.7× 585 0.6× 212 0.7× 13 0.2× 37 0.8× 42 957
Spyros Zissimopoulos United Kingdom 15 673 0.6× 596 0.6× 143 0.4× 50 0.9× 58 1.3× 29 854
Hidetada Yoshida Japan 17 615 0.6× 536 0.6× 128 0.4× 14 0.2× 15 0.3× 22 908
Qun Sha United States 14 551 0.5× 335 0.3× 184 0.6× 18 0.3× 8 0.2× 25 788
Julio Altamirano Mexico 13 430 0.4× 267 0.3× 167 0.5× 12 0.2× 30 0.7× 20 653
Kazuto Yazawa Japan 12 1.3k 1.2× 1.2k 1.3× 471 1.5× 4 0.1× 39 0.9× 16 1.5k

Countries citing papers authored by Marianne E. Buck

Since Specialization
Citations

This map shows the geographic impact of Marianne E. Buck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marianne E. Buck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marianne E. Buck more than expected).

Fields of papers citing papers by Marianne E. Buck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marianne E. Buck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marianne E. Buck. The network helps show where Marianne E. Buck may publish in the future.

Co-authorship network of co-authors of Marianne E. Buck

This figure shows the co-authorship network connecting the top 25 collaborators of Marianne E. Buck. A scholar is included among the top collaborators of Marianne E. Buck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marianne E. Buck. Marianne E. Buck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Broom, Daniel C., David J. Matson, Elizabeth M. Bradshaw, et al.. (2008). Characterization of N-(Adamantan-1-ylmethyl)-5-[(3 R-aminopyrrolidin-1-yl)methyl]-2-chloro-benzamide, a P2X7 Antagonist in Animal Models of Pain and Inflammation. Journal of Pharmacology and Experimental Therapeutics. 327(3). 620–633. 67 indexed citations
2.
Brodbeck, Robbin, Daniel N. Cortright, Jianying Yu, et al.. (2008). Identification and Characterization of NDT 9513727 [N,N-bis(1,3-Benzodioxol-5-ylmethyl)-1-butyl-2,4-diphenyl-1 H-imidazole-5-methanamine], a Novel, Orally Bioavailable C5a Receptor Inverse Agonist. Journal of Pharmacology and Experimental Therapeutics. 327(3). 898–909. 27 indexed citations
3.
Lopes, Coeli M., Patrick G. Gallagher, Marianne E. Buck, Margaret H. Butler, & Steven A. Goldstein. (2000). Proton Block and Voltage Gating Are Potassium-dependent in the Cardiac Leak Channel Kcnk3. Journal of Biological Chemistry. 275(22). 16969–16978. 139 indexed citations
4.
Abbott, Geoffrey W., Federico Sesti, Igor Splawski, et al.. (1999). MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia. Cell. 97(2). 175–187. 1006 indexed citations breakdown →
5.
Pawson, Beverly A., Ruirui Han, Patrick W. Trown, et al.. (1977). ChemInform Abstract: DIHYDRORETINOIC ACIDS AND THEIR DERIVATIVES. SYNTHESIS AND BIOLOGICAL ACTIVITY. Chemischer Informationsdienst. 8(43). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026